The role of FERMT2 in the tumor microenvironment and immunotherapy in pan-cancer using comprehensive single-cell and bulk sequencing

被引:1
|
作者
Wu, Guang-hao [1 ]
He, Chao [2 ]
Che, Gang [2 ]
Zhou, Zheng [2 ]
Chen, Bi-ying [2 ]
Wu, Hai-ming [3 ]
Chen, Jian-feng [3 ]
Zhu, Wei-pu [4 ]
Yang, Yan [2 ]
Zhou, Zhan [5 ,6 ]
Teng, Li-song [2 ]
Wang, Hai-yong [2 ]
机构
[1] Hangzhou Normal Univ, Sch Clin Med, Med Coll, Hangzhou, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Surg Oncol, 79 Qingchun Rd, Hangzhou, Peoples R China
[3] Yiwu Cent Hosp, Dept Gastrointestinal Surg, Jinhua, Peoples R China
[4] Zhejiang Univ, Dept Polymer Sci & Engn, MOE Key Lab Macromol Synth & Functionalizat, Hangzhou, Peoples R China
[5] Zhejiang Univ, Inst Drug Metab & Pharmaceut Anal, Hangzhou, Peoples R China
[6] Zhejiang Univ, Coll Pharmaceut Sci, Zhejiang Prov Key Lab Anticanc Drug Res, Hangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Pan-cancer; Tumor microenvironment; Single-cell transcriptomics; Cancer-associated fibroblasts; TGF-BETA; FIBROBLASTS; KINDLIN-2; EXPRESSION; PROMOTES;
D O I
10.1016/j.heliyon.2024.e30505
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
FERMT2 has been identified as a participant in integrin-linked kinase signaling pathways, influencing epithelial-mesenchymal transition and thereby affecting tumor initiation, progression, and invasion. While the character of FERMT2 in the tumor microenvironment (TME) as well as its implications for immunotherapy remain unclear. Thus, we conducted a comprehensive analysis to assess the prognostic significance of FERMT2 using Kaplan-Meier analysis. In addition, we employed enrichment analysis to uncover potential underlying molecular mechanisms. Using "Immunedeconv" package, we evaluated the immune characteristics of FERMT2 within TME. Furthermore, we determined the expression levels of FERMT2 in various cell types within TME, based on single-cell sequencing data. To confirm the co-expression of FERMT2 and markers of cancer-associated fibroblasts (CAFs), we performed multiplex immunofluorescence staining on tissue paraffin sections across various cancer types. Our analysis disclosed a significant correlation between elevated FERMT2 expression and unfavorable prognosis in specific cancer types. Furthermore, we identified a strong correlation between FERMT2 expression and diverse immune-related factors, including immune checkpoint molecules, immune cell infiltration, microsatellite instability (MSI), and tumor mutational burden (TMB). Additionally, there was a significant correlation between FERMT2 expression and immune-related pathways, particularly those associated with activating, migrating, and promoting the growth of fibroblasts in diverse cancer types. Interestingly, we observed consistent co-expression of FERMT2 in both malignant tumor cells and stromal cells, particularly within CAFs. Notably, our findings also indicated that FERMT2 , in particular, exhibited elevated expression levels within tumor tissues and co -expressed with alpha-SMA in CAFs based on the multiplex immunofluorescence staining results.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] A pan-cancer analysis revealing the role of TIGIT in tumor microenvironment
    Wen, Jie
    Mao, Xueyi
    Cheng, Quan
    Liu, Zhixiong
    Liu, Fangkun
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [32] A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells
    Cheng, Sijin
    Li, Ziyi
    Gao, Ranran
    Xing, Baocai
    Gao, Yunong
    Yang, Yu
    Qin, Shishang
    Zhang, Lei
    Ouyang, Hanqiang
    Du, Peng
    Jiang, Liang
    Zhang, Bin
    Yang, Yue
    Wang, Xiliang
    Ren, Xianwen
    Bei, Jin-Xin
    Hu, Xueda
    Bu, Zhaode
    Ji, Jiafu
    Zhang, Zemin
    CELL, 2021, 184 (03) : 792 - +
  • [33] Pan-cancer spatially resolved single-cell analysis reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment
    Chenxi Ma
    Chengzhe Yang
    Ai Peng
    Tianyong Sun
    Xiaoli Ji
    Jun Mi
    Li Wei
    Song Shen
    Qiang Feng
    Molecular Cancer, 22
  • [34] Pan-cancer analysis of AIM2 inflammasomes with potential implications for immunotherapy in human cancer: A bulk omics research and single cell sequencing validation
    Qin, Yan
    Pan, Liuxian
    Qin, Tianyu
    Ruan, Hanyi
    Zhang, Yujie
    Zhang, Yan
    Li, Jianli
    Yang, Jianrong
    Li, Wei
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [35] A pan-cancer analysis revealing the role of TIGIT in tumor microenvironment
    Jie Wen
    Xueyi Mao
    Quan Cheng
    Zhixiong Liu
    Fangkun Liu
    Scientific Reports, 11
  • [36] Unveiling major histocompatibility complex-mediated pan-cancer immune features by integrated single-cell and bulk RNA sequencing
    Feng, Hao-Ran
    Shen, Xiao-Nan
    Zhu, Xiao-Ming
    Zhong, Wen-Tao
    Zhu, De-Xiang
    Zhao, Ji
    Chen, Yan-Jie
    Shen, Feng
    Liu, Kun
    Liang, Li
    CANCER LETTERS, 2024, 597
  • [37] Application of single-cell sequencing to the research of tumor microenvironment
    Chen, Sijie
    Zhou, Zhiqing
    Li, Yu
    Du, Yuhui
    Chen, Guoan
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [38] Transcriptome and single-cell sequencing analysis in tumor microenvironment
    Liu, Jinhui
    Xie, Jiaheng
    Dong, Peixin
    JOURNAL OF GENE MEDICINE, 2023, 25 (10):
  • [39] Pan-cancer analysis and single-cell analysis identifies the CENPN as a biomarker for survival prognosis and immunotherapy
    Zhang, Nie
    He, Zhuoying
    Qin, Xuejin
    Han, Ke
    Zhu, Zhengchun
    Zhong, Fei
    DISCOVER ONCOLOGY, 2025, 16 (01)
  • [40] The Pan-Cancer Crosstalk Between the EFNA Family and Tumor Microenvironment for Prognosis and Immunotherapy of Gastric Cancer
    Xie, Rongrong
    Yuan, Mengping
    Jiang, Yiyan
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10